About Altasciences
2019 Year in Review
Up Close and Personal with David Grégoire
David Grégoire joined Altasciences as Director of Quality Assurance in 2012.
Up Close and Personal with Mike Broadhurst
Mike Broadhurst joined the Altasciences’ team in 2018.
Brand Identity – Altasciences’ Evolution
Developing a brand identity that fully expresses your company’s contributions is a process that involves understanding your position in the marketplace, establishing your unique selling proposition and associated messaging, developing memorable and impactful creative elements, and finally, implementing strategies to support your brand identity.
Letter From Altasciences' CEO
February 12, 2019
Exceptional service — Lately, it has become an overused expression in our industry. About a year ago, Altasciences set out to explore what exceptional service really means to the people who matter — our clients. After extensive discussions, client surveys, and evaluations, we were pleased to confirm that our early drug development solution offering enables us to provide what our clients want. We also discovered that our brand identity did not accurately communicate our combined early stage drug development capabilities and expertise.
Up Close and Personal with Ingrid Holmes
Ingrid joined Altasciences in 2011, as Vice President of Clinical Operations at the Montreal site, a facility currently housing seven clinical units with 265 beds, and dedicated